Dungan, K. M., Weitgasser, R., Perez Manghi, F., Pintilei, E., Fahrbach, J. L., Jiang, H. H., . . . Robertson, K. E. (2016). A 24‐week study to evaluate the efficacy and safety of once‐weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD‐8). Diabetes Obes Metab.
Stile di citazione ChicagoDungan, K. M., R. Weitgasser, F. Perez Manghi, E. Pintilei, J. L. Fahrbach, H. H. Jiang, J. Shell, e K. E. Robertson. "A 24‐week Study to Evaluate the Efficacy and Safety of Once‐weekly Dulaglutide Added On to Glimepiride in Type 2 Diabetes (AWARD‐8)." Diabetes Obes Metab 2016.
Citazione MLADungan, K. M., et al. "A 24‐week Study to Evaluate the Efficacy and Safety of Once‐weekly Dulaglutide Added On to Glimepiride in Type 2 Diabetes (AWARD‐8)." Diabetes Obes Metab 2016.